NCT00003827View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome

PHASE2UnknownINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

January 31, 1999

Conditions

LeukemiaMyelodysplastic Syndromes

Interventions

DRUG

amifostine trihydrate

DRUG

cytarabine

DRUG

topotecan hydrochloride

Trial Locations (1)

91010-3000

Cancer Center and Beckman Research Institute, City of Hope, Duarte

Sponsors

Lead Sponsor

All Listed Sponsors

lead

ALZA

INDUSTRY